Douglas C. Lane & Associates’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$53M Sell
1,918,338
-34,632
-2% -$958K 1.44% 21
2015
Q3
$50.4M Sell
1,952,970
-7,078
-0.4% -$183K 1.43% 20
2015
Q2
$48.6M Sell
1,960,048
-13,692
-0.7% -$339K 1.31% 24
2015
Q1
$49.7M Sell
1,973,740
-2,334
-0.1% -$58.8K 1.31% 24
2014
Q4
$46.4M Sell
1,976,074
-3,205
-0.2% -$75.2K 1.25% 24
2014
Q3
$45.1M Buy
1,979,279
+8,908
+0.5% +$203K 1.35% 21
2014
Q2
$48.2M Buy
1,970,371
+26,911
+1% +$658K 1.46% 18
2014
Q1
$41M Buy
1,943,460
+51,035
+3% +$1.08M 1.32% 25
2013
Q4
$45.1M Buy
1,892,425
+19,740
+1% +$470K 1.5% 18
2013
Q3
$40.1M Buy
1,872,685
+63,500
+4% +$1.36M 1.46% 18
2013
Q2
$36M Buy
+1,809,185
New +$36M 1.41% 19

Other funds holding QGENF

Douglas C. Lane & Associates's QGENF Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its QIAGEN NV (QGENF) stake by 1.8% in Q4 2015, selling an estimated $958K and leaving 1,918,338 shares worth $53M. The position accounts for 1.44% of the portfolio, ranked #21.

Douglas C. Lane & Associates first reported a position in QGENF in Q2 2013 and has held it in 11 quarters since. 191 funds tracked by Wall St. Rank hold QGENF as of Q4 2015.

  • Douglas C. Lane & Associates held 1,918,338 shares of QIAGEN NV worth $53M as of Q4 2015.
  • Douglas C. Lane & Associates sold 34,632 QIAGEN NV shares in Q4 2015, an estimated $958K.
  • QIAGEN NV made up 1.44% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #21 holding.
  • Douglas C. Lane & Associates first reported a position in QIAGEN NV in Q2 2013 and has held it in 11 quarters since.
  • 191 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.